<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Chernobyl accident":1,
"Children":2,
"Paediatrics":1,
"Radiation":3,
"Secondary cancer":1,
"Thyroid cancer":30,
"Breast cancer":19,
"IL-21":1,
"IL-9":2,
"Th9 cell":1,
"BCSCs":1,
"Exosome":1,
"Invasion":4,
"RAB5B":1,
"miR-130a-3p":1,
"MiR-940":1,
"diagnosis":2,
"prognosis":6,
"Nasopharyngeal carcinoma":1,
"PI3K/AKT":1,
"PVT1":1,
"Tumor stem cell":1,
"miR-1207":1,
"Thyroid":16,
"fine-needle aspiration cytology":2,
"frozen section":1,
"nodule":1,
"Immunotherapy":3,
"Immunotoxicity":1,
"Nonsmall cell lung cancer":1,
"Pembrolizumab":1,
"Pericardial effusion":1,
"Cancer care":1,
"Case review meeting":1,
"Multidisciplinary approach":1,
"Multidisciplinary team":1,
"BRAF mutation":1,
"Case-control studies":1,
"Case-only studies":1,
"Papillary thyroid cancer":8,
"Passive smoking":1,
"Smoking":1,
"Familial adenomatous polyposis":1,
"thyroid cancer screening":1,
"FAP inhibitor":1,
"PET/CT":1,
"fibroblast activation protein":1,
"theranostics":1,
"tracer development":1,
"Graves’ disease":1,
"hemoglobin":1,
"multispectral optoacoustic tomography (MSOT)":1,
"thyroid nodule":9,
"Bethesda":1,
"Citología":1,
"Cytology":2,
"Nódulo tiroideo":1,
"Punción-aspiración con aguja fina":1,
"Artificial intelligence":2,
"Lymphatic metastasis":1,
"Multidetector computed tomography":1,
"CEP78":1,
"WDR62":1,
"lateral lymph node metastasis":1,
"Diagnostic efficiency":1,
"Fine-needle aspiration":4,
"Screening":1,
"Thyroid neoplasms":6,
"Ablation techniques":1,
"High-intensity focused ultrasound ablation":1,
"Interventional ultrasonography":1,
"Nodular goiter":1,
"Pain management":1,
"Familial papillary thyroid carcinoma":1,
"Prognostic factor thyroid microcarcinoma":1,
"Thyroid microcarcinoma":1,
"Breast cancer cell":1,
"Doxorubicin resistance":1,
"NEMO SUMOylation":1,
"NF-κB":1,
"SENP2":1,
"Indeterminate response":1,
"Ongoing risk":1,
"Thyroglobulin":3,
"Ultrasensitive assay":1,
"SETTLE":1,
"histology":2,
"pediatric":2,
"SMAD4":1,
"adenocarcinoma":2,
"carcinoma":4,
"immunohistochemistry":4,
"neoplasm":1,
"pancreas":1,
"protein":1,
"The Cancer Genome Atlas":2,
"microRNA":3,
"overall survival":1,
"papillary thyroid carcinoma":15,
"prognostic markers":1,
"Breast imaging reporting and data system":1,
"Diagnostic performance":1,
"Shear wave velocity":1,
"Virtual touch tissue imaging quantification":2,
"Complication":1,
"Elderly":1,
"Geriatric":1,
"Thyroidectomy":7,
"2015 ATA guidelines":1,
"Extent of thyroidectomy":1,
"Long-term outcomes":1,
"Risk stratification":2,
"Esophageal squamous cell carcinoma (ESCC)":1,
"Ivor–Lewis esophagectomy":1,
"Total pharyngolaryngectomy (TPL)":1,
"NSCLC":1,
"PKM2":2,
"SRSF5":1,
"apoptosis":3,
"glycolysis":2,
"proliferation":2,
"carcinogenesis":1,
"drug resistance":1,
"hepatocellular carcinoma":3,
"oncogenes":1,
"tumour markers":1,
"Africa":1,
"Cancer incidence":1,
"Ecological analysis":1,
"Food availability":1,
"Nutrition transition":1,
"DNMT1":1,
"MGMT":1,
"MS-HRM":1,
"ctDNA":1,
"methylation":1,
"cartilage":1,
"laryngeal cancer":1,
"laser":1,
"transoral":1,
"transoral laser microsurgery":1,
"EMT":3,
"VHL":1,
"miR-21":1,
"Acromegaly":1,
"NF1":1,
"Primary hyperparathyroidism":2,
"Somatotroph adenoma":1,
"Thyroid follicular carcinoma":1,
"death":1,
"risk":1,
"Gastric parietal cell antibody":1,
"Oral leukoplakia":1,
"Oral precancer":1,
"Thyroglobulin antibody":1,
"Thyroid microsomal antibody":1,
"Cancer cell death":1,
"Cancer cell migration":1,
"IL-32":1,
"11β-HSD2":1,
"17β-HSD7":1,
"Mutual regulation":1,
"Receptors":1,
"Steroid sulfatase":1,
"mitochondrial respiration":1,
"targeted therapy":1,
"tigecycline":1,
"Anthracycline":1,
"Basal":1,
"Neo-adjuvant chemotherapy":1,
"Taxane":1,
"Triple negative":1,
"cytologic findings":1,
"follicular variant of papillary thyroid carcinoma":1,
"multinucleated giant cells":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features":1,
"2,3′4,4′,5-Pentachlorobiphenyl":1,
"Cell proliferation":3,
"Hepatocellular carcinoma cells":1,
"follicular lesion of undetermined significance":1,
"follicular neoplasm/suspicious for follicular neoplasm":1,
"pediatric thyroid nodule":1,
"risks of malignancy":1,
"suspicious for malignancy":1,
"Anticorps anti-Scl70":1,
"Autoantibodies":1,
"Cancer":4,
"Crise rénale sclérodermique":1,
"Néoplasie":1,
"Renal Scleroderma crisis":1,
"Sclérodermie":1,
"Systemic sclerosis":1,
"ATM":1,
"Autophagy":2,
"Beclin 1":1,
"G2/M arrest":1,
"Tip60":1,
"Brain metastasis":1,
"Computer-aided diagnosis":2,
"Ultrasonography":5,
"Adrenal cortex":1,
"Adrenocortical carcinoma":1,
"DLK1":1,
"Remodeling":1,
"Steroidogenesis":1,
"Clinicopathologic features":1,
"Genetic mutations":2,
"Nasopharyngeal papillary adenocarcinoma":1,
"Thyroid-like":1,
"Hürthle cells":1,
"ThyroSeq":1,
"fine needle aspiration (FNA)":1,
"molecular":1,
"fluorescent in-situ hybridization":1,
"pharynx":1,
"synovial sarcoma":1,
"STRN-ALK":1,
"dedifferentiation":1,
"p53":1,
"poorly differentiated carcinoma":1,
"Diagnostic imaging":1,
"Lymph nodes":1,
"Salivary gland":1,
"Soft tissue":1,
"Tissue sampling":1,
"Air-flow assisted ionization":1,
"Data processing":1,
"Mass spectrometry imaging":1,
"Spatially resolved metabolomics":1,
"Tumor heterogeneity":1,
"NIS":1,
"dimerization":1,
"radioiodide uptake":1,
"cribriform-morular variant":1,
"familial adenomatous colon polyposis":1,
"lenvatinib":1,
"lung metastasis":1,
"Birthweight":1,
"Cohort":1,
"BRAF":2,
"Fibromatosis/fasciitis-like stroma":1,
"Mutation":2,
"SOX11":1,
"β-Catenin":2,
"Complications":2,
"Concurrent surgical resection":1,
"Esophageal squamous cell carcinoma":1,
"Head and neck cancer":1,
"Second primary malignancy":1,
"Simultaneous":1,
"Survival":1,
"Synchronous":1,
"Inflammation":1,
"L-thyroxine":1,
"Oral cancer":1,
"PD-L1":1,
"Resveratrol":1,
"IGSF1":1,
"metastasis":5,
"CASC2":1,
"CDK19":1,
"Chemoresistance":1,
"miR-18a-5p":1,
"Hyperthyroidism":1,
"CD8+ T cell":1,
"Carcinome hépatocellulaire":1,
"Cutaneous adverse effects":1,
"Effets secondaires cutanés":1,
"Nodular-cystic eruption":1,
"Sorafenib":1,
"Sorafénib":1,
"Éruption nodulo-kystique":1,
"RET proto-oncogene":1,
"S409Y mutation":1,
"medullary thyroid carcinoma":5,
"multiple endocrine neoplasia type 2A":1,
"thyroid neoplasm":2,
"L-triiodothyronine":1,
"combination therapy":1,
"hypothyroidism":1,
"pharmacokinetics":1,
"thyroid hormone withdrawal":1,
"active surveillance":2,
"systematic review and meta-analysis":1,
"Grave's":1,
"nodules":1,
"2-D shear wave elastography":1,
"Conventional US":1,
"Immunohistochemical subtypes":1,
"epithelial":1,
"papillary":1,
"pigmented":1,
"sella":1,
"tumor":1,
"follicular neoplasm":1,
"growth kinetics":1,
"malignancy":1,
"volume doubling time":1,
"LncRNA":3,
"SNHG6":1,
"VASP":2,
"miR-26a":1,
"differentiated thyroid cancer":3,
"dynamic risk":1,
"risk of recurrence":1,
"Cell migration":1,
"TRIM63":1,
"Wnt/β-catenin signaling pathway":2,
"BC, breast cancer":1,
"BMI, body mass index":1,
"CI, confidence interval":1,
"CNS, central nervous system":1,
"Cohort study":1,
"DMF, dimethyl fumarate":1,
"DMT":1,
"DMT, disease modifying treatment":1,
"EBV, Epstein-Barr virus":1,
"GA, glatiramer acetate":1,
"Glossary: MS, multiple sclerosis":1,
"HL, Hodgkin lymphoma":1,
"ICD, International Classification of Diseases":1,
"IFN, interferon":1,
"IS, immunosuppressant":1,
"MRI, magnetic resonance image":1,
"Multiple sclerosis":1,
"OR, odds ratio":1,
"PPMS, primary progressive MS":1,
"RRMS, relapsing remitting MS":1,
"SPMS, secondary progressive MS":1,
"TFR, teriflunomide":1,
"Long non-coding RNA":1,
"MIAT":1,
"ceRNA":1,
"miR-212":1,
"low-risk cancer":1,
"nonsurgical treatment":1,
"Anticancer drug":1,
"Clinical trials":1,
"HDAC inhibitors":1,
"HDACs":1,
"TERT activation":1,
"copy number change":1,
"promoter activity":1,
"promoter mutation":1,
"CDKN1A":1,
"MTC":1,
"RET":4,
"SNP":1,
"meta-analysis":2,
"risk association":1,
"Calcitonin":4,
"DICER1":1,
"Hereditary medullary thyroid carcinoma":1,
"RET Oncogene":1,
"TRIP6":1,
"endometrial carcinoma":1,
"miR-589-5p":1,
"migration":1,
"ANKRD26":1,
"Expression analysis RET":1,
"RET rearrangement":1,
"RET/PTC":1,
"GEO":1,
"nomogram":1,
"radioactive iodine":1,
"surgical outcomes":1,
"3D printing":1,
"Medical image":1,
"Phantom":1,
"Diet":1,
"Dietary factors":1,
"Dietary patterns":1,
"EZR gene":1,
"TERT":2,
"polymorphism":1,
"Biomarker":2,
"HEIH":1,
"MiR-4458":1,
"SOCS1":1,
"Coexistence":1,
"Hashimoto’s disease":1,
"mucosa-associated lymphoid tissue lymphoma":1,
"primary thyroid diffuse large B cell lymphoma":1,
"primary thyroid lymphoma":1,
"molecular genetics":1,
"Breast neoplasms":1,
"Laparoscopy":2,
"Mammaplasty":1,
"Mastectomy, radical":1,
"bioinformatics analysis":1,
"ryanodine receptor 2":1,
"thyroid carcinoma":9,
"Wnt":1,
"microRNA-300":1,
"regulation of nuclear pre-mRNA domain-containing protein 1B":1,
"Ablation techniques/methods":1,
"Neoplasm metastases":1,
"Spine":1,
"ALK":1,
"PDTC":1,
"anaplastic lymphoma kinase":1,
"poorly differentiated thyroid cancer":1,
"F-18-Dopa PET/CT":1,
"increased calcitonin":1,
"whole-body MRI":1,
"RFA":1,
"Thyroid ablation":1,
"benign nodule":1,
"laser ablation":1,
"malignant nodule":1,
"Core needle biopsy":3,
"Technique":1,
"Ultrasound":2,
"Aurora kinase inhibitor":1,
"PF-03814735":1,
"drug design":1,
"epigenetics":1,
"telomerase":1,
"mutant p53":1,
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit α":1,
"target inhibitor":1,
"telomerase reverse transcriptase":1,
"Krebs cycle":1,
"PTEN hamartoma tumor syndrome":1,
"autism spectrum disorder":1,
"hereditary cancer":1,
"neurodevelopmental disorders":1,
"targeted metabolomics":1,
"autoimmune thyroiditis":1,
"causality":1,
"nuclear receptors":1,
"reverse transcription-semiquantitative PCR":1,
"CD44v6":1,
"TTF-1":1,
"large cell undifferentiated carcinoma":1,
"small cell undifferentiated carcinoma":1,
"undifferentiated lung carcinoma":1,
"ambient mass spectrometry":1,
"cancer diagnosis":1,
"metabolic profiles":1,
"molecular biomarkers":1,
"thyroid nodule diagnosis":1,
"2019":1,
"Adult":1,
"Anaplastic thyroid cancer":1,
"Asian - Japanese":1,
"Bronchoscopy*":1,
"CT scan":1,
"Coughing":1,
"FT3":1,
"FT4":1,
"Female":1,
"Haemoptysis":1,
"Histopathology":2,
"Japan":1,
"Levatinib":1,
"October":1,
"TSH":1,
"Thyroid antibodies":1,
"Thyroid transcription factor-1":2,
"Thyroid ultrasonography":1,
"Thyroxine (T4)":1,
"Triiodothyronine (T3)":1,
"Unique/unexpected symptoms or presentations of a disease":1,
"3,3,5-triiodo-L-thyronine (T3), L-thyroxine (T4), cancer proliferation":1,
"thyroid hormone":2,
"thyroid hormone receptor":1,
"Biological Sciences":1,
"Genomics":1,
"Fine needle aspiration":1,
"Molecular diagnositic techniques":1,
"Cancer registry":1,
"Incidence":2,
"Mortality":1,
"Surveillance":1,
"Papillary carcinoma thyroid":2,
"retropharyngeal node":1,
"tracheal infiltration":1,
"neck dissection":1,
"submental node":1,
"Atypia of undetermined significance":2,
"risk of malignancy":1,
"subcategory":1,
"thyroid cytopathology":1,
"Classification rate":1,
"Connection combination":1,
"Reinforcement residual network":1,
"Sal-deep network":1,
"Visual attention mechanisms":1,
"DNA fragility":1,
"DNA repair":1,
"DNA topoisomerases":1,
"TOP2 cleavage complex":1,
"chromatin organization":1,
"topoisomerases and disease":1,
"germline mutations":1,
"pathway analysis":1,
"predisposition markers":1,
"whole genome sequencing":1,
"BRAFV600E":1,
"RAS":2,
"convolutional neural network":1,
"deep learning":1,
"T-cell lymphoma":1,
"hand":1,
"peripheral":1,
"primary cutaneous":1,
"Differentiated thyroid carcinoma":1,
"Levothyroxine":1,
"TSH replacement therapy":1,
"TSH suppressive therapy":1,
"Thyroid-stimulating hormone":1,
"FIr-B/FOx":1,
"NEC":1,
"Neuroendocrine carcinoma":1,
"Subcutaneous metastasis":1,
"Triplet chemotherapy plus bevacizumab":1,
"Carcinoembryogenic antigen":1,
"Adiposity":1,
"Body mass index":1,
"Thyroid nodules":3,
"Visceral fat area":1,
"Acute invasive fungal infection":1,
"Ibrutinib":1,
"Mucormycosis":1,
"Iodine-131 therapy":1,
"Long-term follow-up":1,
"Nuclear medicine":1,
"Granular cell tumor":1,
"Pituicytoma":1,
"Transsphenoidal":1,
"genetic polymorphism":1,
"susceptibility":1,
"trefoil factor 3":1,
"frontolateral vertical partial laryngectomy":1,
"laryngeal carcinoma":1,
"laryngeal function reconstruction":1,
"titanium mesh":1,
"Benign thyroid disease":1,
"Menopause":1,
"Thyroid disorders":1,
"BRAF V600E":1,
"Extent of surgery":1,
"Molecular testing":1,
"Endoscopy":1,
"Narrow Band Imaging":1,
"Parathyroid Neoplasms":1,
"Video-Assisted Surgery":1,
"CD200":1,
"HNSCC":1,
"anaplastic and poorly differentiated thyroid carcinoma":1,
"oncolytic virus":1,
"liver cancer":1,
"oxidative stress":1,
"7th and 8th edition of AJCC staging system":1,
"Clinical significance":1,
"Pancreatic head and body-tail cancers":1,
"Multiple endocrine Neoplasia":1,
"Neurilemomma":1,
"Papillary carcinoma":1,
"Postoperative complications":1,
"Cancer genetics":1,
"Colon cancer":1,
"BMI":1,
"risk factor":1,
"complete response":1,
"immune adverse events":1,
"nephrectomy":1,
"nivolumab":1,
"renal cell carcinoma":1,
"thyroid dysfunction":1,
"vitiligo":1,
"second primary cancer":1,
"GPR68":1,
"OGR1":1,
"antibody":1,
"neuroendocrine":1,
"tumours":1,
"epidemiology":1,
"structural equation models":1,
"water":1,
"HMGA2":1,
"molecular markers":1,
"preoperative diagnosis":1,
"Androgen receptor":1,
"Androgen signal":1,
"PSA":1,
"ACR TI-RADS":1,
"American Thyroid Association (ATA) guidelines":1,
"Indeterminate":1,
"Case report":1,
"MEN type 1":1,
"MEN type 4":1,
"Parathyroid carcinoma":2,
"Pituitary adenoma":1,
"Pituitary apoplexy":1,
"AJCC 8th edition Cancer Staging Manual":1,
"Extra thyroid extension (ETE)":1,
"Locally advanced thyroid cancer":1,
"Well-differentiated thyroid carcinoma (WDTC)":1,
"Hashimoto’s thyroiditis":1,
"PTPRC":1,
"locally invasive thyroid tumors":1,
"multikinase inhibitors":1,
"neoadjuvant therapy":1,
"unresectable thyroid tumors":1,
"pathology":2,
"ratio":1,
"diagnostic techniques":1,
"amyloid":1,
"carcinoembryonic antigen":1,
"hyperparathyroidism":2,
"men2":1,
"pheochromocytoma":1,
"Endocrine Oncology":1,
"parathyroid disease":1,
"parathyroidectomy":1,
"Low-risk differentiated thyroid cancer":1,
"Radioiodine treatment":1,
"Recurrence":1,
"Relapse":1,
"CT":1,
"DTC":1,
"MRI":1,
"Post-therapeutic whole-body scan (WBS) with I-131":1,
"Follicular":1,
"Mandible":1,
"Neoplasm metastasis":1,
"aloperine":1,
"131I treatment":1,
"cohort studies":1,
"diagnostic whole body scan":1,
"Doppler ultrasonography":1,
"neoplasms":1,
"thyroid gland":1,
"Associated lesions":1,
"Microcarcinoma":1,
"Thyroid malignancies":1,
"Variants":1,
"EFVPTC":1,
"Encapsulated":1,
"NIFTWP":1,
"Non-invasive follicular":1,
"Re-nomenclature":1,
"Ectopic thyroid":1,
"Lingual thyroid":1,
"Lingual thyroid carcinoma":1,
"Bethesda classification":1,
"FNAC":1,
"TIRAD":1,
"Thyroid swelling":1,
"USG":1,
"Central lymph node dissection":1,
"Lymph node metastasis":1,
"Hypocalcemia":1,
"Recurrent laryngeal nerve injury":1,
"Surgical complications":1,
"Vocal cord palsy":1,
"clinical evidence":1,
"endocrine tumors":1,
"lithium":1,
"mechanism of action":1,
"pre-clinical evidence":1,
"CREB1":1,
"Lin28":1,
"miR-638":1,
"Iodine-refractory":1,
"Regorafenib":1,
"Myoma":1,
"Rising thyroglobulin":1,
"Tumor spread":1,
"anoikis":1,
"integrin β4":1,
"lymphovascular tumor thrombus":1,
"Neoadjuvant chemotherapy":1,
"Pathological complete response":1,
"Tumor recurrence":1,
"EFEMP2":1,
"Focus Harmonic Scalpel":1,
"Hypocalcaemia":1,
"Hypoparathyroidism":1,
"Pituitary metastasis":1,
"minimally invasive follicular thyroid carcinoma":1,
"medullary carcinoma":1,
"therapy":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2019年10月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
